BeStock  

Baxter International Inc BAX

US equityMarket cap rank #1210Medical Instruments & Supplies
$25.39 +$0.00 (0.00%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $25.43 +0.16%
Open$25.45
Prev close$25.39
Day range$24.85 – $26.09
Volume4.32M
Market cap$13.14B
P/E (TTM)–
Dividend yield0.16%

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership103.5%0.00 pts vs. prior quarter
Institutions holding886-1 vs. prior quarter
Insider trades (recent)24 buys / 16 sellsNet buying
Short interest4.58% of floatDays to cover 3.0 · as of 30 Oct 2026
Short-sale volume share27.7%5-day average of daily volume

Short-sale volume as % of daily volume

16%23%30%37%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$42.23M (5 inflow days, 15 outflow days).

Net flow by order size, last 20 sessions

−$30.3MSuper−$11.9MBig−$22.9MMid−$26.0MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 48.8% of shares outstanding.

Largest holders

  • BlackRock12.67%
  • Pzena Investment Management, Inc.12.07%
  • Dodge & Cox10.76%
  • Vanguard Capital Management, LLC7.12%
  • FMR6.20%
  • Vanguard Portfolio Management, LLC4.53%
  • State Street Global Advisors3.99%
  • Strategic Advisers LLC3.74%

By investor type

  • Mutual Fund91.73%
  • Hedge Fund4.23%
  • Public Company2.98%
  • Private Company2.24%
  • Government Pension Fund1.08%
  • Sovereign Wealth Fund0.81%
  • Individual/Insider0.42%
  • Insurance Company0.17%

Reported short interest has held roughly steady near 4.58% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Citadel Advisors LLC Hedge Fund 2026/Q4 +4,758,748 1.0%
AQR Capital Management Hedge Fund 2026/Q4 +4,575,540 1.3%
Freestone Grove Partners LP Hedge Fund 2026/Q4 +2,110,084 0.5%
Morgan Stanley Public Company 2026/Q4 +1,243,621 0.8%
Columbia Management Investment Advisers, LLC Mutual Fund 2026/Q4 +1,144,436 0.3%
Nomura Holdings, Inc. Public Company 2026/Q4 +1,066,596 0.2%
WEDGE Capital Management LLP Mutual Fund 2026/Q4 +1,065,501 0.2%
Goldman Sachs Asset Management, L.P. Mutual Fund 2026/Q4 +813,504 1.1%
Citigroup Inc. Public Company 2026/Q4 +595,821 0.2%
Nuveen Asset Management LLC Insurance Company 2026/Q4 +545,166 0.1%
Aegon Asset Management UK Plc Mutual Fund 2026/Q4 +537,953 0.1%
Trexquant Investment LP Hedge Fund 2026/Q4 +419,388 0.1%
Mariner, LLC Mutual Fund 2026/Q4 +368,806 0.1%
Strategic Advisers LLC Mutual Fund 2026/Q4 +351,921 3.7%
Millennium Management LLC Hedge Fund 2026/Q4 +348,108 0.1%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
30 Sep 2026 John Rogers Chief Financial Officer Initial Statement of Beneficial +0 – –
14 Sep 2026 Bernie Heine Interim Chief Accounting Officer & Controller Initial Statement of Beneficial +0 – 32,840
1 Sep 2026 Andrew Hider CEO, Pres., Interim Group Pres. of Medical Products & Therapies and Director Sale to Issuer -54,276 $25.70 71,276
1 Sep 2026 Julie Foster President of Front Line Care Sale to Issuer -2,098 $25.70 29,164
31 Aug 2026 James Teaff President of Care & Connectivity Solutions Sale to Issuer -750 $25.48 30,370
1 Jun 2026 Steven Wallace President of Advanced Surgery & Commercial Excellence Sale to Issuer -153 $18.68 70,128
1 Jun 2026 James Teaff President of Care & Connectivity Solutions Sale to Issuer -321 $18.68 31,063
31 May 2026 Anita Zielinski Former Interim CFO, Senior VP, Chief Accounting Officer & Controller Other Acquisition +13,426 – 55,705
4 May 2026 Michael McDonnell Independent Director Other Acquisition +12,836 – 14,647
4 May 2026 Amy McBride-Wendell Independent Director Other Acquisition +12,836 – 44,235
4 May 2026 Patricia Morrison Independent Director Other Acquisition +12,836 – 42,386
4 May 2026 Nancy Schlichting Independent Director Other Acquisition +12,836 – 34,994
4 May 2026 David Shafer Independent Chairperson Other Acquisition +12,836 – 72,804
4 May 2026 Jeffrey Craig Independent Director Other Acquisition +12,836 – 23,662
4 May 2026 David Wilkes Independent Director Other Acquisition +12,836 – 37,076
4 May 2026 William Ampofo Independent Director Other Acquisition +12,836 – 30,375
31 Mar 2026 Steven Wallace President of Advanced Surgery & Commercial Excellence Initial Statement of Beneficial +0 – 67,972
31 Mar 2026 Julie Foster President of Front Line Care Initial Statement of Beneficial +0 – 25,862
31 Mar 2026 James Teaff President of Care & Connectivity Solutions Initial Statement of Beneficial +0 – 55,119
5 Mar 2026 Joel Grade Former Chief Financial Officer Sale to Issuer -8,153 $17.69 74,520

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 23,674,982 4.6% 3.0
15 Oct 2026 23,765,665 4.6% 4.2
30 Sep 2026 24,366,869 4.7% 3.0
15 Sep 2026 23,227,313 4.5% 4.5
31 Aug 2026 23,293,667 4.5% 5.0
14 Aug 2026 23,914,369 4.6% 3.0

Discussion

No comments yet — be the first to weigh in on BAX.

Sign in to join the discussion.

Scroll to Top